
pmid: 17601550
I would like to congratulate Dr. Persson and colleagues for their recently published echocardiographic substudy of the CHARM (Candesartan in Heart Failure—Assessment of Reduction in Mortality and Morbidity)-Preserved trial ([1][1]). Their results emphasize the importance of an objective evaluation
Heart Failure, Male, Ventricular Remodeling, Prognosis, Severity of Illness Index, Survival Analysis, Echocardiography, Doppler, Ventricular Dysfunction, Left, Diastole, Humans, Female, Cardiology and Cardiovascular Medicine
Heart Failure, Male, Ventricular Remodeling, Prognosis, Severity of Illness Index, Survival Analysis, Echocardiography, Doppler, Ventricular Dysfunction, Left, Diastole, Humans, Female, Cardiology and Cardiovascular Medicine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
